These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 2998022)
41. Type 2 poliovirus recombinants isolated from vaccine-associated cases and from healthy contacts in Brazil. Friedrich F; Da-Silva EF; Schatzmayr HG Acta Virol; 1996 Feb; 40(1):27-33. PubMed ID: 8886095 [TBL] [Abstract][Full Text] [Related]
42. Recombination and rescue between temperature-sensitive mutants of poliovirus type 1. Agut H; Bellocq C; van der Werf S; Girard M Virology; 1984 Dec; 139(2):393-402. PubMed ID: 6097032 [TBL] [Abstract][Full Text] [Related]
43. Complete nucleotide sequence of the attenuated poliovirus Sabin 1 strain genome. Nomoto A; Omata T; Toyoda H; Kuge S; Horie H; Kataoka Y; Genba Y; Nakano Y; Imura N Proc Natl Acad Sci U S A; 1982 Oct; 79(19):5793-7. PubMed ID: 6310545 [TBL] [Abstract][Full Text] [Related]
44. Analysis of genome composition and reactogenicity of recombinants of cold-adapted and virulent virus strains. Ghendon YZ; Klimov AI; Alexandrova GI; Polezhaev FI J Gen Virol; 1981 Apr; 53(Pt 2):215-24. PubMed ID: 7264609 [TBL] [Abstract][Full Text] [Related]
45. Rational design of genetically stable, live-attenuated poliovirus vaccines of all three serotypes: relevance to poliomyelitis eradication. Macadam AJ; Ferguson G; Stone DM; Meredith J; Knowlson S; Auda G; Almond JW; Minor PD J Virol; 2006 Sep; 80(17):8653-63. PubMed ID: 16912313 [TBL] [Abstract][Full Text] [Related]
46. Isolation and characterization of recombinants between attenuated and virulent aphthovirus strains. Giraudo AT; Sagedahl A; Bergmann IE; La Torre JL; Scodeller EA J Virol; 1987 Feb; 61(2):419-25. PubMed ID: 3027372 [TBL] [Abstract][Full Text] [Related]
47. Molecular genetic analysis of revertants from a poliovirus mutant that is specifically adapted to the mouse spinal cord. Jia Q; Hogle JM; Hashikawa T; Nomoto A J Virol; 2001 Dec; 75(23):11766-72. PubMed ID: 11689657 [TBL] [Abstract][Full Text] [Related]
48. Attenuated influenza B virus recombinants obtained by crossing of B/England/2608/76 virus with a cold-adapted B/Leningrad/14/17/55 strain. Medvedeva TE; Gordon MA; Ghendon YZ; Klimov AI; Alexandrova GI Acta Virol; 1983 Jul; 27(4):311-7. PubMed ID: 6195900 [TBL] [Abstract][Full Text] [Related]
49. [Primary structure of the crossover region in the genome of two intertype poliovirus recombinant]. Romanova LI; Viktorova EG; Tol'skaia EA; Kolesnikova MS; Guseva EA Bioorg Khim; 1985 Dec; 11(12):1685-7. PubMed ID: 3002394 [TBL] [Abstract][Full Text] [Related]
50. Internal ribosomal entry site substitution eliminates neurovirulence in intergeneric poliovirus recombinants. Gromeier M; Alexander L; Wimmer E Proc Natl Acad Sci U S A; 1996 Mar; 93(6):2370-5. PubMed ID: 8637880 [TBL] [Abstract][Full Text] [Related]
51. Characterization of CHAT and Cox type 1 live-attenuated poliovirus vaccine strains. MartÃn J; Minor PD J Virol; 2002 Jun; 76(11):5339-49. PubMed ID: 11991962 [TBL] [Abstract][Full Text] [Related]
52. Genetic recombination of poliovirus in vitro and in vivo: temperature-dependent alteration of crossover sites. Duggal R; Wimmer E Virology; 1999 May; 258(1):30-41. PubMed ID: 10329565 [TBL] [Abstract][Full Text] [Related]
53. Reversion to neurovirulence of the live-attenuated Sabin type 3 oral poliovirus vaccine. Cann AJ; Stanway G; Hughes PJ; Minor PD; Evans DM; Schild GC; Almond JW Nucleic Acids Res; 1984 Oct; 12(20):7787-92. PubMed ID: 6093054 [TBL] [Abstract][Full Text] [Related]
54. Physical mapping of herpes simplex virus-coded functions and polypeptides by marker rescue and analysis of HSV-1/HSV-2 intertypic recombinants. Wilkie NM; Stow ND; Marsden HS; Preston V; Cortini R; Timbury MC; Subak-Sharpe JH IARC Sci Publ (1971); 1978; (24 Pt 1):11-31. PubMed ID: 221322 [TBL] [Abstract][Full Text] [Related]
55. Sequence studies of poliovirus RNA. IV. Nucleotide sequence complexities of poliovirus type 1, type 2 and two type 1 defective interfering particles RNAs, and fingerprint of the poliovirus type 3 genome. Lee YF; Kitamura N; Nomoto A; Wimmer E J Gen Virol; 1979 Aug; 44(2):311-22. PubMed ID: 230285 [TBL] [Abstract][Full Text] [Related]
56. Towards development of an in vitro translation test for poliovirus neurovirulence. Svitkin YV; Alpatova GA; Lipskaya GA; Maslova SV; Agol VI; Kew O; Meerovitch K; Sonenberg N Dev Biol Stand; 1993; 78():27-32. PubMed ID: 8388829 [TBL] [Abstract][Full Text] [Related]
57. Analysis of neutralization-escape mutants selected from a mouse virulent type 1/type 2 chimeric poliovirus: identification of a type 1 poliovirus with antigenic site 1 deleted. Couderc T; Martin A; Wychowski C; Girard M; Horaud F; Crainic R J Gen Virol; 1991 Apr; 72 ( Pt 4)():973-7. PubMed ID: 1707949 [TBL] [Abstract][Full Text] [Related]
58. Attenuation and reversion of the Sabin vaccine strains of poliovirus. Minor PD Dev Biol Stand; 1993; 78():17-26. PubMed ID: 8388828 [TBL] [Abstract][Full Text] [Related]
59. Recombinants of influenza virus type B as potential live vaccine candidates: RNA characterization and evaluation in man. Lobmann M; Delem A; Jovanovic D; Peetermans J J Hyg (Lond); 1981 Aug; 87(1):43-52. PubMed ID: 7019320 [TBL] [Abstract][Full Text] [Related]
60. The temperature sensitivity of the Sabin type 3 vaccine strain of poliovirus: molecular and structural effects of a mutation in the capsid protein VP3. Minor PD; Dunn G; Evans DM; Magrath DI; John A; Howlett J; Phillips A; Westrop G; Wareham K; Almond JW J Gen Virol; 1989 May; 70 ( Pt 5)():1117-23. PubMed ID: 2543771 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]